Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Neelam Tejpal, M.S.

Neelam Tejpal, M.S.

 

Neelam Tejpal

Neelam Tejpal, M.S.

Instructor
The Methodist Hospital Research Institute

Email: ntejpal@houstonmethodist.org
Phone: 713-441-6869


Education

B.S.   Government College, Chandigarh, India (Biology, Chemistry)
M.S.   Punjab University, Chandigarh, India (Genetics)

Biography

Ms. Tejpal is a graduate of Punjab University of Chandigarh, India and holds a Masters Degree in Genetics. She joined the staff in the Department of Surgery at The University of Texas Medical School at Houston in 1980 as a Research Assistant in the Division of Immunology and Organ Transplantation. She was promoted to Research Associate there in 1986, and to Research Scientist in 1990. She assumed her current positions at Methodist in 2008.

Description of Research

Ms. Tejpal’s research focus is on synthetic compounds that disrupt selectin-mediated cell surface interactions. Her work has been published in esteemed journals such as Blood and the Journal of Immunology.

Major Areas of Research

Immunology, organ transplantation, selectin-mediated cell surface interactions

Recent Publications

Zhang Y, Kirken RA, Furian L, Janczewska S, Qu X, Hancock WW, Wang M, Tejpal N, Kerman R, Kahan BD, Stepkowski SM. Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells. J Immunol. 2006 Jan 1;176(1):128-37.

Stepkowski SM, Kao J, Wang ME, Tejpal N, Podder H, Furian L, Dimmock J, Jha A, Das U, Kahan BD, Kirken RA. The Mannich base NC1153 promotes long-term allograft survival and spares the recipient from multiple toxicities. J Immunol. 2005 Oct 1;175(7):4236-46.

Stepkowski SM, Kirken RA, Trawick BW, Wang M, Tejpal N, Wang ME, Tian L, Clark J, Kahan BD. Allochimeric class I MHC protein-induced tolerance by partial TCR engagement requires activation of both CTL4- and common gamma-chain-dependent cytokine signals. Transplantation. 2002 Apr 27;73(8):1227-35.

Stepkowski SM, Erwin-Cohen RA, Behbod F, Wang ME, Qu X, Tejpal N, Nagy ZS, Kahan BD, Kirken RA. Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin. Blood. 2002 Jan 15;99(2):680-9.

Stepkowski SM, Kirken RA, Nagy ZS, Trawick BW, Wang M, Tejpal N, Wang ME, Tian L, Clark J, Kahan BD. The role of Stat5 in the induction of regulatory T cells in transplantation tolerance. Transplant Proc. 2001 Nov-Dec;33(7-8):3835-6.

Kahan BD. The role of Stat5 in the induction of regulatory T cells in transplantation tolerance. Transplant Proc. 2001 Nov-Dec;33(7-8):3835-6.